FGF1 Protects MCF-7 Cells against Taltobulin through Both the MEKs/ERKs and PI3K/AKT Signaling Pathway

Breast cancer is a widespread and complex disease characterized by abnormal signaling pathways that promote tumor growth and progression. Despite significant medical advances and the development of increasingly effective therapies for breast cancer, drug resistance and reduced sensitivity to prior t...

Descripción completa

Detalles Bibliográficos
Autores principales: Szymczyk, Jakub, Czyrek, Aleksandra, Otlewski, Jacek, Zakrzewska, Malgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376943/
https://www.ncbi.nlm.nih.gov/pubmed/37509496
http://dx.doi.org/10.3390/biomedicines11071856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376943/
https://www.ncbi.nlm.nih.gov/pubmed/37509496
http://dx.doi.org/10.3390/biomedicines11071856

Ejemplares similares